Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

GlaxoSmithKline Pakistan Ltd (GLAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
101.80 +3.72    +3.79%
03/05 - Closed. Currency in PKR ( Disclaimer )
  • Volume: 226,500
  • Bid/Ask: 100.00 / 101.77
  • Day's Range: 97.31 - 101.80
Type:  Equity
Market:  Pakistan
ISIN:  PK0001301016 
S/N:  GLAXO
GlaxoSmithKline Pakistan 101.80 +3.72 +3.79%

GLAX Balance Sheet

 
Featured here, the Balance Sheet for GlaxoSmithKline Pakistan Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 25340.64 26806.62 24018.1 25329.95
Cash and Short Term Investments 3610.76 3824.1 1562.86 2314.72
Cash - - - -
Cash & Equivalents 3610.76 3824.1 1562.86 2314.72
Short Term Investments - - - -
Total Receivables, Net 8586.86 9320.54 9268.21 10834.55
Accounts Receivables - Trade, Net 1028.47 1032.2 1182.99 1905.69
Total Inventory 11793.96 13336.55 12952.75 11889.62
Prepaid Expenses 190.74 - - -
Other Current Assets, Total 1158.32 325.43 234.27 291.06
Total Assets 38130.9 39097.57 36162.55 37437.66
Property/Plant/Equipment, Total - Net 11700.56 11217.22 11073.43 11066.66
Property/Plant/Equipment, Total - Gross 18933.78 - - -
Accumulated Depreciation, Total -7233.22 - - -
Goodwill, Net 955.74 - - 955.74
Intangibles, Net - 955.74 955.74 -
Long Term Investments - - - -
Note Receivable - Long Term 7505.82 6871.25 6518.59 7342.67
Other Long Term Assets, Total 50.15 33.23 33.23 27.52
Other Assets, Total 4501.8 5843.29 5567.49 2990.1
Total Current Liabilities 14564.72 16947.58 13769.27 14377.1
Accounts Payable 1615.98 5882.15 4295.38 4902.89
Payable/Accrued - - - -
Accrued Expenses 5403.87 5477.35 3971.34 3294.17
Notes Payable/Short Term Debt 572.93 - - -
Current Port. of LT Debt/Capital Leases 35.94 11.94 12.76 18.22
Other Current liabilities, Total 6936 5576.13 5489.8 6161.82
Total Liabilities 16455.06 18436.09 15431.28 15953.99
Total Long Term Debt 116.04 13.76 19.22 20.07
Long Term Debt - - - -
Capital Lease Obligations 116.04 13.76 19.22 20.07
Deferred Income Tax 1180.6 797.12 997.1 945.23
Minority Interest - - - -
Other Liabilities, Total 20.78 677.62 645.69 611.58
Total Equity 21675.84 20661.49 20731.28 21483.67
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3184.67 3184.67 3184.67 3184.67
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 17364.25 16349.89 16419.68 17172.07
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 1126.92 1126.92 1126.92 1126.92
Total Liabilities & Shareholders' Equity 38130.9 39097.57 36162.55 37437.66
Total Common Shares Outstanding 318.47 317.23 318.47 318.47
Total Preferred Shares Outstanding - - - -
* In Millions of PKR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GLAX Comments

Write your thoughts about GlaxoSmithKline Pakistan Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email